Highlights from the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis

Bruyère, Olivier; Reginster, Jean-Yves

doi:10.1517/14656566.8.11.1779

Request a copy

Article (Scientific journals)

Highlights from the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis

Bruyère, Olivier; Reginster, Jean-Yves

2007 • In Expert Opinion on Pharmacotherapy, 8 (11), p. 1779-1784

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/20683

DOI
10.1517/14656566.8.11.1779

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Highlights from the Seven European Congress on Clinical and Economic Aspects of OP and OA.pdf

Publisher postprint (2.57 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

bone mineral density cost-effective; fracture; osteoarthritis; osteoporosis; quality of life

Abstract :

[en] The Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO), which was held in Porto between March 28 and March 30, 2007, was the largest meeting in Europe in the field of osteoporosis and osteoarthritis. The meeting was attended by similar to 4000 scientists and health professionals seeking information on the epidemiology, pathogenesis, prevention and treatment of osteoporosis and osteoarthritis. Specifically addressing these topics, > 500 abstracts were submitted. This paper highlights and summarises the important findings of ECCEO 2007.

Disciplines :

General & internal medicine

Author, co-author :

Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique

Language :

English

Title :

Highlights from the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis

Publication date :

August 2007

Journal title :

Expert Opinion on Pharmacotherapy

ISSN :

1465-6566

eISSN :

1744-7666

Publisher :

Informa Healthcare, London, United Kingdom

Volume :

Issue :

Pages :

1779-1784

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 01 September 2009

Statistics

Number of views

56 (5 by ULiège)

Number of downloads

3 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

SEEMAN, E., Why do bones break? A reappraisal of mechanisms of bone fragility (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S1-S2
HAENTJENS, P., BOONEN, S., Excess mortality after hip fracture among postmenopausal women and ageing men: Evidence from data searches and life-table analyses for gender-related differences in absolute risk of death after hip fracture (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S5-S6
STRÖM, O., BORGSTRÖM, F., ZETHRAEUS, N., JOHNELL, O., JöNSSON, B., Long term quality of life related to osteoporotic fractures. 13-18 months after fracture (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S6
SZULC, P., DELMAS, P.D., Prevalent falls predict incident non-vertebral fractures in elderly men - prospective minos study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S5
HADJI, P., NICKELSEN, T., MARIN, F., Bone mineral density response to 2 years of continuous treatment with teriparatide: Final results from the eurofors study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S7
DELMAS, P.D., SILVERMAN, S.L., WATTS, N.B., LANGE, J.L., LINDSAY, R., Risedronate and alendronate for the reduction of nonvertebral fractures, a retrospective cohort study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S7-S8
FELSENBERG, D., MILLER, P.D., LEWIECKI, E.M., LIBANATI, C., LIU, Y., BECK, T.J., Hip structural analysis of the proximal femur in postmenopausal women with low bone mass treated with denosumab (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S9
LYNCH, N.O., EARNSHAW, S.R., GRAHAM, C.N., MIDDELHOVEN, H., Cost-effectivenss of ibandronate injection IV in the treatment of uk women with postmenopausal osteoporosis who are intolerant to oral bispbosphonates (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S11-S12
STOCH, S.A., MILLER, D.L., VAN DYCK, K., Effect of cathepsin k inhibition on bone resorption markers in healthy postmenopausal women (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S8-S9
LIPS, P., PFEIFER, M., WALLISER, J., Treatment effects of vitamin d3 8400 iu once weekly on body sway of elderly subjects with vitamin D insufficiency (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S11
BOONEN, S., WARDLAW, D., BASTIAN, L., LIPS, R., VAN MEIRHAEGHE, J., CUMMINGS, S., International multicenter randomized comparison of balloon kyphoplasty and non-surgical management in patients with acute vertebral body compression fractures (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S10-S11
REGINSTER, J.-Y., BRIXEN, K., CORMIER, C., CANNATA, J., Strontium ranelate demonstrates vertebral and non-vertebral anti fracture efficacy including hip fractures over 5 years in post menopausal osteoporotic women (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S21
BLACK, D.M., DELMAS, P.D., EASTELL, R., Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: The horizon pivotal fracture trial (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S21
CHAPURLAT, R.D., ARLOT, M., BURT-PICHAT, B., Effect of long-term bisphosphonates on bone turnover and microdamage in osteoporotic women: A bone biopsy study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S10
JUNG, T.I., VON DER GABLENTZ, J., FELSENBERG, D., Osteonecrosis of the jaw under bisphosphonate therapy - a german register for patents with osteonecrosis of the jaw (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S8
DERE, W., Are anti-osteoporotic agents the solution for treating osteoarthritis? (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S2-S3
ZHAI, G., HART, D.J., KATO, B.S., SHARMA, L., MACGREGOR, A., SPECTOR, T.D., Genetic contribution to knee radiographic osteoarthritis and knee alignment: A longitudinal twin study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S12
MARTEL-PELLETIER, J., RAYNAULD, J.P., BERTHIAUME, M.J., The loss of cartilage volume/thickness on the weight bearing areas in knee osteoarthritic patients, assessed by quantitative MRI, is correlated with severity of symptoms and worsening of pain over time (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S12-S13
BEATTIE, K.A., DURYEA, J., PUI, M., The contribution of medial femoral and tibial cartilage thickness to minimum joint space width in osteoarthritic knees (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S13
BEATTIE, K.A., DURYEA, J., PUI, M., Minimum joint space width values in healthy individuals and patients with knee OA (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S13-S14
HUELS, J., OMAR, M., DUBOIS, R.W., DOAN, Q.V., Lumiracoxib is cost-effective compared with celecoxib and NSAID plus proton pump inhibitor combinations for the management of osteoarthritis among patients with a prior gastrointestinal event in the United Kingdom (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S14
KAHAN, A., VIGNON, E., UEBELHART, D., REGINSTER, J.-Y., A randomized controlled trial with chondroitin sulfate involving over 600 patients: STOPP (study on osteoarthritis progressinn prevention) (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S14-S15
HERRERO-BEAUMONT, G., BRANCO, J., FOR, T.G., INVESTIGATORS. Glucosamine sulfate improves quality of life of knee osteoarthritis patients in the glucosamine unum in die efficacy (GUIDE) trial (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S16
BRUYÈRE, O., DELFERRIERE, D., ROUX, C., FECHTENBAUM, J., KOLTA, S., REGINSTER, J.-Y., Strontium ranelate prevents spine osteoarthritis progression in patients with prevalent spinal osteoarthritis (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S16-S17
PELLETIER, J.-P., RAYNAULD, J.-P., BIAS, P., Licofelone, a 5-lipoxygenase and cyclooxygenase inhibitor, reduces the progression of knee osteoarthritis (OA): A double blind, multicenter two-year study using quantitative MRI (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S18
COHEN, S.B., VALEN, P., RITCHLIN, C., Inhibition of rank1 with denosumab decreases progression of bone erosions in patients with rheumatoid arthritis: MRI results at 6 months (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S15-S16
LANE, N., IANNINI, M., ATKINS, C., Inhibition of RANKL with denosumab reduces markers of bone and cartilage turnover in patients with rheumatoid arthritis (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S17-S18
QUESADA GÓMEZ JM, C.X., RAMÍREZ, E., Adherence to therapeutic recommendation for calcium + vitamin D supplementation in the pharmacologic treatment of postmenopausal osteoporosis in spain: The combicad study (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S19
PIERCY, J., BADAMGARAV, E., TIMPERS, E., TOMPKINS, R., Impact of incomplete patient compliance with medication instructions for bisphosphonate therapy on healthcare utilization and quality of life (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S19
RABENDA, V., REGINSTER, J.-Y., Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S19-520
DANESE, M., BADAMGARAV, E., BAUER, D., Poor patient adherence to osteoporosis treatment is associated with an increased rate and cost of hip fracture (2007) Osteoporos. Int, 18 (SUPPL. 1), pp. S20